ARCHIVES

Blumenthal Names Presidential Advisor; Groups Lobby To Limit Her Influence

This article is from The Cancer Letter archive.

Vol. 23 No. 38 | October 3, 1997

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

July 30, 2004

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

September 28, 2012

NCI Seeks Nominations For Consumer Liaison Group.

November 23, 2001

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

July 11, 2014

In Brief: Hellman to Leave Memorial This Fall For Position As Dean, Vice President at Univ. Of Chicago

April 8, 1988

DCPC Advisers Ok Four New Grant Programs To Foster Prevention

May 22, 1992